Abstract:Background Pars plana vitrectomy (PPV) is a main method of treating severe proliferative diabetic retinopathy (PDR) , but intraoperative bleeding often occurs, which affects the intraoperative process and final prognosis.Intravitreal injection of ranibizumab (IVR), a vascular endothelial growth factor (VEGF) monoclonal antibody,has been used in PPV,so the evaluation of therapeutic effect and safety of PPV associated by IVR is very important.Objective This study was to evaluate the effect of IVR-assisted 23G PPV on patients with severe PDR.Methods The clinical data of 82 eyes of 77 patients with severe PDR who received 23G PPV from August 2012 to December 2013 were respectively analyzed,including 49 eyes undergone IV R-assisted 23G PPV (IVR combined with PPV group) and 33 eyes undergone 23G PPV only (simple PPV group).IVR (0.5 mg/0.05 ml) was performed on the eyes 5-7 days before PPV in the IVR combined with PPV group,and only PPV was carried out in the simple PPV group.Operative duration, endodiathermy times, incidence of iatrogenic retinal holes, best corrected visual acuity (BCVA) (LogMAR), postoperative bleeding, re-operation rate, Ⅰ phase attached rate of retinas, occurrence rate of neovascular glaucoma and temporary ocular hypertension rate were compared between the two groups.Results The average operation duration was (71.90-± 26.42) minutes in the IVR combined with PPV group, which was significantly shorter than (96.76±25.15) minutes in the simple PPV group (t =-4.300, P＜0.05).Endodiathermy time in the IVR combined with PPV group was significantly less than that in the simple PPV group (0.76±0.14 versus 2.18±1.64) (x2 =-4.284,P＜0.01).The BCVA at postoperative 3 months was (0.70±0.50) and (0.74±0.50) in the IVR combined with PPV group and simple PPV group,which was significantly improved in comparison with before operation (1.73±0.50,1.70±0.470) respectively (t=-0.151,0.118,both at P＜0.01),but no significant difference in the postoperative BCVA between the two groups (t =-0.318, P =0.758).The incidence of iatrogenic retinal holes was significantly lower in the IVR combined with PPV group than that in the simple PPV group (6.12％ versus 21.20％) (x2 =4.193 ,P=0.041).In addition,the postoperative bleeding rate was also significantly different between the IVR combined with PPV group and the simple PPV group (2.04％ versus 15.15％) (x2=6.580, P=0.010).No significant differences were seen in the incidence of re-operation rate, I phase attached rate of retinas,occurrence rate of neovascular glaucoma and temporary ocular hypertension rate between two groups (all at P＞O.05).Conclusions IVR before 23G PPV can reduce the risk of intravitreal bleeding during operation and after surgery,shorten operation duration and lessen the incidence of iatrogenic retinal break.The BCVA after IVR-assisted PPV improves as good as simple PPV.

23 G Minimally Invasive Vitrectomy for Vitreous Hemorrhage Resulted Form Retinal Vein Occlusion (RVO)

Therapeutic effect and safety of 23G pars plana vitrectomy assisted by ranibizumab for severe proliferative diabetic retinopathy

Effect of 23G Vitreous Lavage in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage

Comparison of 23G and 20G Vitrectomy for Diabetic Retinopathy

The 23G and 20G Vitrectomy for Patients with Diabetic Retinopathy

Non-Buckled Vitrectomy for Retinal Detachment with Inferior Breaks and Proliferative Vitreoretinophathy

Vitrectomy for retinal detachment secondary to branch retinal vein occlusion

Minimally Invasive Vitreoretinal Surgery (25G, 27G) with High-speed Vitrectomy Cutter – Case Series

23G Minimally Invasive Vitrectomy Combined with Glaucoma Drainage Valve Implantation and Phacoemulsification Cataract Extraction for Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy with Vitreous Hemorrhage

23-Gauge Vitrectomy Combined with Phacoemulsification and Intraocular Lenses Implantation for Proliferative Diabetic Retinopathy with Coexisting Cataract

Clinical effect of small-gauge vitrectomy for proliferative diabetic retinopathy with tractional retinal detachment

Combined Treatment of Minimally Invasive 23-G Vitrectomy and Chandelier for Superior Bullous Rhegmatogenous Retinal Detachment.

The Experience of Vitrectomy for Diabetic Retinopathy with Rubeosis Iridis after Intravitreal Injection of Ranibizumab

Vitreous surgery with direct central retinal artery massage for central retinal artery occlusion

Traumatic Retinal Detachment Associated with Giant Retinal Tear Treated with 25-Gauge Pars Plana Vitrectomy

Comparison of 27-gauge and 25-gauge vitrectomy in the management of tractional retinal detachment secondary to proliferative diabetic retinopathy

Vitrectomy combined with drainage valve implantation for the treatment of neovascular glaucoma

Vitrectomy with Intraocular Cyclophotocoagulation for the Treatment of Neovascular Glaucoma

Management of Non-Inferior Rhegmatognous Retinal Detachment with Vitrectomy and Air Tamponade

A systematic review and meta-analysis of clinical outcomes of small gauge vitrectomy with or without intravitreal antivascular endothelial growth factor agents pretreatment for proliferative diabetic retinopathy

Observations on vitrectomy for vitreomacular traction syndrome